Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,413 | -16,921 | -36,317 | -38,700 | -24,123 |
| Depreciation Amortization | 870 | 379 | 3,192 | 2,469 | 1,641 |
| Accounts payable and accrued liabilities | 368 | 135 | 667 | 1,509 | 852 |
| Other Working Capital | -7,628 | -6,749 | -4,023 | 226 | -1,401 |
| Other Operating Activity | 4,260 | 1,506 | -14,941 | 46 | 149 |
| Operating Cash Flow | $-37,543 | $-21,650 | $-51,422 | $-34,450 | $-22,882 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -525 | -65 | -321 | -193 | -111 |
| Purchase Of Investment | -42,654 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 49,500 | 30,000 | 5,000 | 0 | N/A |
| Other Investing Activity | 0 | 0 | 20,958 | 0 | 0 |
| Investing Cash Flow | $6,321 | $29,935 | $25,637 | $-193 | $-111 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 92,343 | N/A | N/A |
| Debt Repayment | -27 | -11 | -29 | -21 | -11 |
| Common Stock Issued | 1,044 | 629 | 168 | 167 | 132 |
| Other Financing Activity | -7,142 | -7,142 | 0 | -1,961 | -100 |
| Financing Cash Flow | $-6,125 | $-6,524 | $92,482 | $-1,815 | $21 |
| Beginning Cash Position | 148,718 | 148,718 | 82,021 | 82,021 | 82,021 |
| End Cash Position | 111,371 | 150,479 | 148,718 | 45,563 | 59,049 |
| Net Cash Flow | $-37,347 | $1,761 | $66,697 | $-36,458 | $-22,972 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,543 | -21,650 | -51,422 | -34,450 | -22,882 |
| Capital Expenditure | -525 | -65 | -321 | -193 | -111 |
| Free Cash Flow | -38,068 | -21,715 | -51,743 | -34,643 | -22,993 |